Connect with us

HEALTH

Midlands State University to get marijuana licence

Published

on

AMON-MURWIRA

Midlands State University (MSU) has applied for a licence to grow marijuana for medicinal purposes following the Government’s legalisation of marijuana farming last year.

Addressing students at MSU during a public lecture in Gweru, Higher and Tertiary Education, Science and Technology Development Minister Professor Amon Murwira said Government was in the process of licensing the university to grow cannabis for medicinal purposes.

Prof Murwira said there several other institutions that would also be growing marijuana.

He said Government intends to reduce its import bill by having local pharmaceuticals producing medicines from local resources.
“We were told by our former colonial masters that marijuana is illegal and they even promulgated a law prohibiting the smoking of marijuana. However, it has medicinal properties. So our leadership had a closer look and realised that marijuana can be useful and then legalised the growing of marijuana for medicinal purposes. So we have started doing so. MSU itself has applied for a licence for growing marijuana,” he said.

Prof Murwira said universities should be innovative and incubate ideas in their innovation hubs.

“Resources are nothing but they become when we have the brains of using them. This is very important. We need to look inside. When we do physics, we need to be able to use it and apply it here in Zimbabwe. We probably have the same amount of resources but different levels of development.

“We always want people outside to make things for us. We want our biochemistry to work for us. Most of the medicines that we have come from trees, roots and other plants. These are the product of our environment. So what we want to do is that the medicines that we are going to be using in the country should come from our own pharmacies and resources found in the country.

“I cannot be treated by medicine that was made from an environment that I am not living in. This is why people die because they are not suitable for us,” he said.

Prof Murwira said all Ministers of State have been asked to avail 20 hectares each for industrial hubs where the incubated ideas will then be implemented and operationalised. The Herald

Continue Reading
Advertisement
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

sixteen − 13 =

HEALTH

Perence Shiri, Zimbabwe Agriculture Minister Dies

Published

on

Perrence-Shiri-Dead

Zimbabwe’s agriculture minister Perence Shiri, a retired general who helped plot the ouster of Robert Mugabe in a 2017 coup, has died, President Emmerson Mnangagwa said on Wednesday.

Perence Shiri, who commanded the air force for 25 years until he joined the government in 2017, was admitted to hospital on Tuesday, two government sources said. He died in the early hours of Wednesday.

“Shiri was a true patriot, who devoted his life to the liberation, independence and service of his country,” Mnangagwa said in a statement. He did not say how Shiri died.

But domestic media said Shiri, 65, succumbed to complications from the respiratory disease caused by the coronavirus, which has infected 2,817 and killed 40 in Zimbabwe.

A liberation war veteran,Perrence Shiri had a chequered past. He commanded the army’s Fifth Brigade unit that carried out the 1980s massacres of thousands of civilians in western Zimbabwe as the government sought to quell an insurgency.

The army massacres, known as ‘Gukurahundi’, a Shona term meaning the ‘early rain that washes away the chaff’, remain a sore point for the people of the Matabeleland region, many of whom demand justice and reparations.

The main opposition Movement for Democratic Change accused Perence Shiri of being among the security chiefs who organised violence against its members after Mugabe lost the first round of the presidential vote in 2008.Reuters

Continue Reading

HEALTH

US buys nearly all of Gilead’s Covid-19 drug Remdesivir

Published

on

Remdesivir Covid 19

The US is buying nearly all the next three months’ projected production of Covid-19 treatment Remdesivir from US manufacturer Gilead.

The US health department announced on Tuesday it had agreed to buy 500,000 doses for use in American hospitals. Tests suggest Remdesivir cuts recovery times, though it is not yet clear if it improves survival rates.

Gilead did sign a licensing deal in May for production outside the US but it is still in its early stages.

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” Department of Health and Human Services Secretary Alex Azar said in a statement. A course of treatment in the US will cost $2,340 (£1,900).

Nine companies can make the drug under licence outside the US for distribution in 127 mostly poorer countries, and the cost is lower. But the project is still in its early stages.

Additional quantities are being manufactured for use in clinical trials. But critics say the US move to buy up so much stock from Gilead itself undermines international co-operation on COVID, given that other countries have taken part in trials of Remdesivir, originally an anti-viral against Ebola.

“The trial that gave the result that allowed Remdesivir to sell their drug wasn’t just done in the US. There were patients participating through other European countries, in the UK as well, and internationally, Mexico and other places,” Oxford University’s Prof Peter Horby told BBC Radio 4.

He said the move also had implications for any possible future vaccine, with the need for “a much stronger framework if we are going to develop these things and they’re going to be used for national emergencies”.

Senior Sussex University lecturer, Ohid Yaqub, said: “It so clearly signals an unwillingness to co-operate with other countries and the chilling effect this has on international agreements about intellectual property rights.”Some in the US have criticised the purchase price, as taxpayer money had helped fund Remdesivir’s development.BBC

Continue Reading

HEALTH

17 new Zimbabwe Covid-19 cases confirmed

Published

on

Zimbabwe Covid 19

Seventeen new cases of Covid-19 in Zimbabwe, a majority of which are from quarantine facilities were reported yesterday bringing the total number of cases to 591.

From the cases confirmed yesterday, 13 involved returnees from South Africa, one from Botswana while three were local transmissions. The Ministry of Health and Child Care daily update shows that one of the cases confirmed as a local transmission had to contact with a known confirmed case.

Investigations are, however, underway to establish the source of infection for the two other local transmissions. Cases of recoveries also continue to increase with the latest statistics from the update standing at 162, leaving the country with 421 active COVID 19 cases.

The latest recoveries were reported from Mashonaland East (3), Mashonaland Central (2), Bulawayo (2), Matabeleland North (2), Mashonaland West (1) and Manicaland (1). The number of people who have died from the virus remains at seven.

“To date, the total number of confirmed cases is 591, recovered 162, active cases, 422 and seven deaths since the onset of the outbreak on 20 March 2020,” reads part of the update.

Zimbabwe has so far conducted 67 755 tests for Covid-19 from which, 30 711 were diagnostic tests while the remaining were rapid tests done for screening purposes. The Herald

Continue Reading

Trending